Showing results (11-20 of 117) with videos related to
Sort By:
Pageof 12
Chembiochem : a European Journal of Chemical Biology|January 6, 2010
Glyco-scan: varying glycosylation in the sequence of the peptide hormone PYY3-36 and its effect on receptor selectivitySøren L Pedersen, Catharina Steentoft, Niels Vrang, et al.American Journal of Translational Research|May 2, 2013
Novel insight into the distribution of L-cells in the rat intestinal tractCarl Frederik Hansen, Niels Vrang, Per Torp Sangild, et al.Brain Research|April 17, 2007
Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nucleiNiels Vrang, Mikkel Hansen, Philip Just Larsen, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|September 10, 2009
Modifying the conserved C-terminal tyrosine of the peptide hormone PYY3-36 to improve Y2 receptor selectivitySøren L Pedersen, Birgitte Holst, Niels Vrang, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 26, 2003
Gastric distension induces c-Fos in medullary GLP-1/2-containing neuronsNiels Vrang, Curtis B Phifer, Michele M Corkern, et al.Brain Research|February 16, 2008
The putative neuropeptide TAFA5 is expressed in the hypothalamic paraventricular nucleus and is regulated by dehydrationSarah Juel Paulsen, Mads Tang Christensen, Niels Vrang, et al.Chemmedchem|February 26, 2010
Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effectsSøren L Pedersen, Pottayil G Sasikumar, Niels Vrang, et al.Journal of Chemical Neuroanatomy|July 5, 2003
Projections from the raphe nuclei to the suprachiasmatic nucleus of the ratAnders Hay-Schmidt, Niels Vrang, Philip J Larsen, et al.Journal of Diabetes Research|March 9, 2016
The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic MiceHelena Cucak, Gitte Hansen, Niels Vrang, et al.The Journal of Endocrinology|July 5, 2012
The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic miceJacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, et al.Pageof 12